Panel Discussion: Applying AI & Advanced Data Analytics to Transform Biomarker Discovery & Clinical Trial Strategy for Improved Precision Medicine Programs

• Application of AI across the precision medicine value chain what are the most promising, low-hanging fruits and least promising? 
• Where can foundation models help inform clinical biomarker and diagnostic strategies?  
• Pharma opportunities for AI applications – partnerships, infrastructure and considerations? 

Speakers:

Emanuele De Rinaldis

Vice President & Global Head, Target, Diseases & Systems Biology

Sanofi

Karim Azer

Global Head, Data & AI, Clinical Development

Novartis

Mike Washburn

Executive Director & Head, Integrative Sciences, Oncology Translational Medicine

GSK

J. Carl Barrett

CSA

Independent Expert